Global Gene Subcloning Service 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI02254282

Publication Date:

February 27, 2025

Pages:

127

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Gene Subcloning Service market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Gene subcloning services are offered by various biotechnology companies or research facilities to assist researchers and scientists in manipulating and transferring specific genes or DNA fragments into different plasmids or expression vectors.
United States market for Gene Subcloning Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Gene Subcloning Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Gene Subcloning Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Gene Subcloning Service players cover Thermo Fisher Scientific, Eurofins Scientific, Merck KGaA, Genscript Biotech Corp, Synbio Technologies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淕ene Subcloning Service Industry Forecast鈥� looks at past sales and reviews total world Gene Subcloning Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Gene Subcloning Service sales for 2025 through 2031. With Gene Subcloning Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Subcloning Service industry.
This Insight Report provides a comprehensive analysis of the global Gene Subcloning Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Subcloning Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Gene Subcloning Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Subcloning Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Subcloning Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Subcloning Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Stranded Gene
Complex Gene
Others
Segmentation by Application:
Academic and Research Institutions
Clinical Laboratories
Pharmaceutical and Biotechnology Companies
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Eurofins Scientific
Merck KGaA
Genscript Biotech Corp
Synbio Technologies
Bio Basic
Bioneer Corporation
Applied Biological Materials
Takara Bio
Canvax Biotech
Codex DNA
Azenta US
Macrogen
InvivoGen
BioCat GmbH
BEX Co., Ltd
Lonza Group

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Gene Subcloning Service 麻豆原创 Size (2020-2031)
2.1.2 Gene Subcloning Service 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Gene Subcloning Service by Country/Region (2020, 2024 & 2031)
2.2 Gene Subcloning Service Segment by Type
2.2.1 Stranded Gene
2.2.2 Complex Gene
2.2.3 Others
2.3 Gene Subcloning Service 麻豆原创 Size by Type
2.3.1 Gene Subcloning Service 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Gene Subcloning Service 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Gene Subcloning Service Segment by Application
2.4.1 Academic and Research Institutions
2.4.2 Clinical Laboratories
2.4.3 Pharmaceutical and Biotechnology Companies
2.4.4 Other
2.5 Gene Subcloning Service 麻豆原创 Size by Application
2.5.1 Gene Subcloning Service 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Gene Subcloning Service 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Gene Subcloning Service 麻豆原创 Size by Player
3.1 Gene Subcloning Service 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Gene Subcloning Service Revenue by Player (2020-2025)
3.1.2 Global Gene Subcloning Service Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Gene Subcloning Service Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Gene Subcloning Service by Region
4.1 Gene Subcloning Service 麻豆原创 Size by Region (2020-2025)
4.2 Global Gene Subcloning Service Annual Revenue by Country/Region (2020-2025)
4.3 Americas Gene Subcloning Service 麻豆原创 Size Growth (2020-2025)
4.4 APAC Gene Subcloning Service 麻豆原创 Size Growth (2020-2025)
4.5 Europe Gene Subcloning Service 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Gene Subcloning Service 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Gene Subcloning Service 麻豆原创 Size by Country (2020-2025)
5.2 Americas Gene Subcloning Service 麻豆原创 Size by Type (2020-2025)
5.3 Americas Gene Subcloning Service 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Subcloning Service 麻豆原创 Size by Region (2020-2025)
6.2 APAC Gene Subcloning Service 麻豆原创 Size by Type (2020-2025)
6.3 APAC Gene Subcloning Service 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Gene Subcloning Service 麻豆原创 Size by Country (2020-2025)
7.2 Europe Gene Subcloning Service 麻豆原创 Size by Type (2020-2025)
7.3 Europe Gene Subcloning Service 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gene Subcloning Service by Region (2020-2025)
8.2 Middle East & Africa Gene Subcloning Service 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Gene Subcloning Service 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Gene Subcloning Service 麻豆原创 Forecast
10.1 Global Gene Subcloning Service Forecast by Region (2026-2031)
10.1.1 Global Gene Subcloning Service Forecast by Region (2026-2031)
10.1.2 Americas Gene Subcloning Service Forecast
10.1.3 APAC Gene Subcloning Service Forecast
10.1.4 Europe Gene Subcloning Service Forecast
10.1.5 Middle East & Africa Gene Subcloning Service Forecast
10.2 Americas Gene Subcloning Service Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Gene Subcloning Service Forecast
10.2.2 Canada 麻豆原创 Gene Subcloning Service Forecast
10.2.3 Mexico 麻豆原创 Gene Subcloning Service Forecast
10.2.4 Brazil 麻豆原创 Gene Subcloning Service Forecast
10.3 APAC Gene Subcloning Service Forecast by Region (2026-2031)
10.3.1 China Gene Subcloning Service 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Gene Subcloning Service Forecast
10.3.3 Korea 麻豆原创 Gene Subcloning Service Forecast
10.3.4 Southeast Asia 麻豆原创 Gene Subcloning Service Forecast
10.3.5 India 麻豆原创 Gene Subcloning Service Forecast
10.3.6 Australia 麻豆原创 Gene Subcloning Service Forecast
10.4 Europe Gene Subcloning Service Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Gene Subcloning Service Forecast
10.4.2 France 麻豆原创 Gene Subcloning Service Forecast
10.4.3 UK 麻豆原创 Gene Subcloning Service Forecast
10.4.4 Italy 麻豆原创 Gene Subcloning Service Forecast
10.4.5 Russia 麻豆原创 Gene Subcloning Service Forecast
10.5 Middle East & Africa Gene Subcloning Service Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Gene Subcloning Service Forecast
10.5.2 South Africa 麻豆原创 Gene Subcloning Service Forecast
10.5.3 Israel 麻豆原创 Gene Subcloning Service Forecast
10.5.4 Turkey 麻豆原创 Gene Subcloning Service Forecast
10.6 Global Gene Subcloning Service Forecast by Type (2026-2031)
10.7 Global Gene Subcloning Service Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Gene Subcloning Service Forecast
11 Key Players Analysis
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific Gene Subcloning Service Product Offered
11.1.3 Thermo Fisher Scientific Gene Subcloning Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Information
11.2.2 Eurofins Scientific Gene Subcloning Service Product Offered
11.2.3 Eurofins Scientific Gene Subcloning Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Eurofins Scientific Main Business Overview
11.2.5 Eurofins Scientific Latest Developments
11.3 Merck KGaA
11.3.1 Merck KGaA Company Information
11.3.2 Merck KGaA Gene Subcloning Service Product Offered
11.3.3 Merck KGaA Gene Subcloning Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Merck KGaA Main Business Overview
11.3.5 Merck KGaA Latest Developments
11.4 Genscript Biotech Corp
11.4.1 Genscript Biotech Corp Company Information
11.4.2 Genscript Biotech Corp Gene Subcloning Service Product Offered
11.4.3 Genscript Biotech Corp Gene Subcloning Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Genscript Biotech Corp Main Business Overview
11.4.5 Genscript Biotech Corp Latest Developments
11.5 Synbio Technologies
11.5.1 Synbio Technologies Company Information
11.5.2 Synbio Technologies Gene Subcloning Service Product Offered
11.5.3 Synbio Technologies Gene Subcloning Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Synbio Technologies Main Business Overview
11.5.5 Synbio Technologies Latest Developments
11.6 Bio Basic
11.6.1 Bio Basic Company Information
11.6.2 Bio Basic Gene Subcloning Service Product Offered
11.6.3 Bio Basic Gene Subcloning Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Bio Basic Main Business Overview
11.6.5 Bio Basic Latest Developments
11.7 Bioneer Corporation
11.7.1 Bioneer Corporation Company Information
11.7.2 Bioneer Corporation Gene Subcloning Service Product Offered
11.7.3 Bioneer Corporation Gene Subcloning Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Bioneer Corporation Main Business Overview
11.7.5 Bioneer Corporation Latest Developments
11.8 Applied Biological Materials
11.8.1 Applied Biological Materials Company Information
11.8.2 Applied Biological Materials Gene Subcloning Service Product Offered
11.8.3 Applied Biological Materials Gene Subcloning Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Applied Biological Materials Main Business Overview
11.8.5 Applied Biological Materials Latest Developments
11.9 Takara Bio
11.9.1 Takara Bio Company Information
11.9.2 Takara Bio Gene Subcloning Service Product Offered
11.9.3 Takara Bio Gene Subcloning Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Takara Bio Main Business Overview
11.9.5 Takara Bio Latest Developments
11.10 Canvax Biotech
11.10.1 Canvax Biotech Company Information
11.10.2 Canvax Biotech Gene Subcloning Service Product Offered
11.10.3 Canvax Biotech Gene Subcloning Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Canvax Biotech Main Business Overview
11.10.5 Canvax Biotech Latest Developments
11.11 Codex DNA
11.11.1 Codex DNA Company Information
11.11.2 Codex DNA Gene Subcloning Service Product Offered
11.11.3 Codex DNA Gene Subcloning Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Codex DNA Main Business Overview
11.11.5 Codex DNA Latest Developments
11.12 Azenta US
11.12.1 Azenta US Company Information
11.12.2 Azenta US Gene Subcloning Service Product Offered
11.12.3 Azenta US Gene Subcloning Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 Azenta US Main Business Overview
11.12.5 Azenta US Latest Developments
11.13 Macrogen
11.13.1 Macrogen Company Information
11.13.2 Macrogen Gene Subcloning Service Product Offered
11.13.3 Macrogen Gene Subcloning Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 Macrogen Main Business Overview
11.13.5 Macrogen Latest Developments
11.14 InvivoGen
11.14.1 InvivoGen Company Information
11.14.2 InvivoGen Gene Subcloning Service Product Offered
11.14.3 InvivoGen Gene Subcloning Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 InvivoGen Main Business Overview
11.14.5 InvivoGen Latest Developments
11.15 BioCat GmbH
11.15.1 BioCat GmbH Company Information
11.15.2 BioCat GmbH Gene Subcloning Service Product Offered
11.15.3 BioCat GmbH Gene Subcloning Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 BioCat GmbH Main Business Overview
11.15.5 BioCat GmbH Latest Developments
11.16 BEX Co., Ltd
11.16.1 BEX Co., Ltd Company Information
11.16.2 BEX Co., Ltd Gene Subcloning Service Product Offered
11.16.3 BEX Co., Ltd Gene Subcloning Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.16.4 BEX Co., Ltd Main Business Overview
11.16.5 BEX Co., Ltd Latest Developments
11.17 Lonza Group
11.17.1 Lonza Group Company Information
11.17.2 Lonza Group Gene Subcloning Service Product Offered
11.17.3 Lonza Group Gene Subcloning Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.17.4 Lonza Group Main Business Overview
11.17.5 Lonza Group Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.